212 related articles for article (PubMed ID: 6504632)
41. Metabolic responses to early and high protein supplementation in a randomized trial evaluating the prevention of hyperkalemia in extremely low birth weight infants.
Blanco CL; Falck A; Green BK; Cornell JE; Gong AK
J Pediatr; 2008 Oct; 153(4):535-40. PubMed ID: 18589451
[TBL] [Abstract][Full Text] [Related]
42. Effect of prenatal T4 treatment in neonatal morbidity: preliminary findings.
Reyes G; Romaguera J; Zapata R; Valcarcel M; Adamsons K
P R Health Sci J; 1997 Mar; 16(1):5-8. PubMed ID: 9160396
[TBL] [Abstract][Full Text] [Related]
43. Effect of vitamin E therapy on blood coagulation tests in newborn infants.
Zipursky A; Milner RA; Blanchette VS; Johnston MA
Pediatrics; 1980 Oct; 66(4):547-50. PubMed ID: 7001332
[TBL] [Abstract][Full Text] [Related]
44. Severe intraventricular hemorrhage in preterm infants: comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage.
Sarkar S; Bhagat I; Dechert R; Schumacher RE; Donn SM
Am J Perinatol; 2009 Jun; 26(6):419-24. PubMed ID: 19267317
[TBL] [Abstract][Full Text] [Related]
45. The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants.
Malloy MH; Cutter GR
J Perinatol; 1995; 15(3):185-91. PubMed ID: 7666265
[TBL] [Abstract][Full Text] [Related]
46. Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.
Berseth CL; Van Aerde JE; Gross S; Stolz SI; Harris CL; Hansen JW
Pediatrics; 2004 Dec; 114(6):e699-706. PubMed ID: 15545616
[TBL] [Abstract][Full Text] [Related]
47. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial.
Lin HC; Hsu CH; Chen HL; Chung MY; Hsu JF; Lien RI; Tsao LY; Chen CH; Su BH
Pediatrics; 2008 Oct; 122(4):693-700. PubMed ID: 18829790
[TBL] [Abstract][Full Text] [Related]
48. Intraventricular hemorrhage in the premature infant--current concepts. Part II.
Volpe JJ
Ann Neurol; 1989 Feb; 25(2):109-16. PubMed ID: 2645823
[TBL] [Abstract][Full Text] [Related]
49. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants.
Bedard MP; Shankaran S; Slovis TL; Pantoja A; Dayal B; Poland RL
Pediatrics; 1984 Apr; 73(4):435-9. PubMed ID: 6369238
[TBL] [Abstract][Full Text] [Related]
50. [Semi-micromethod for the assay of vitamin E. Use in neonatal pharmacology].
Kersaudy L; Georges P; Olive G
Ann Biol Clin (Paris); 1976; 34(5):317-22. PubMed ID: 1015668
[TBL] [Abstract][Full Text] [Related]
51. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries.
van Hasselt PM; de Koning TJ; Kvist N; de Vries E; Lundin CR; Berger R; Kimpen JL; Houwen RH; Jorgensen MH; Verkade HJ;
Pediatrics; 2008 Apr; 121(4):e857-63. PubMed ID: 18381514
[TBL] [Abstract][Full Text] [Related]
52. Influence on retrolental fibroplasia of intramuscular vitamin E administration during respiratory distress syndrome.
Puklin JE; Simon RM; Ehrenkranz RA
Ophthalmology; 1982 Feb; 89(2):96-103. PubMed ID: 7041039
[TBL] [Abstract][Full Text] [Related]
53. Protective effect of vitamin E on intraventricular haemorrhage in the newborn.
Chiswick ML; Johnson M; Woodhall C; Gowland M; Davies J; Toner N; Sims D
Ciba Found Symp; 1983; 101():186-200. PubMed ID: 6360588
[TBL] [Abstract][Full Text] [Related]
54. Protective effect of vitamin E (DL-alpha-tocopherol) against intraventricular haemorrhage in premature babies.
Chiswick ML; Johnson M; Woodhall C; Gowland M; Davies J; Toner N; Sims DG
Br Med J (Clin Res Ed); 1983 Jul; 287(6385):81-4. PubMed ID: 6407714
[TBL] [Abstract][Full Text] [Related]
55. Meta-analysis of phenobarbital usage for prevention of intraventricular hemorrhage in premature infants: factors related to variation in outcome.
Tholl DA; Miller TQ; Henderson WG; Myers TF
Clin Trials Metaanal; 1994 Oct; 29(2-3):177-90. PubMed ID: 10150225
[TBL] [Abstract][Full Text] [Related]
56. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial.
Johnson L; Quinn GE; Abbasi S; Otis C; Goldstein D; Sacks L; Porat R; Fong E; Delivoria-Papadopoulos M; Peckham G
J Pediatr; 1989 May; 114(5):827-38. PubMed ID: 2654350
[TBL] [Abstract][Full Text] [Related]
57. Vitamin E for prevention of perinatal intracranial hemorrhage.
Poland RL
Pediatrics; 1990 May; 85(5):865-7. PubMed ID: 2184412
[No Abstract] [Full Text] [Related]
58. The role of vitamin E therapy in high-risk neonates.
Phelps DL
Clin Perinatol; 1988 Dec; 15(4):955-63. PubMed ID: 3061710
[TBL] [Abstract][Full Text] [Related]
59. Evidence for the safety of ascorbic acid administration to the premature infant.
Bass WT; Malati N; Castle MC; White LE
Am J Perinatol; 1998 Feb; 15(2):133-40. PubMed ID: 9514139
[TBL] [Abstract][Full Text] [Related]
60. [Clinical application of fat soluble vitamins to retinopathy of prematurity and intracranial hemorrhage].
Shirahata A
Nihon Rinsho; 1993 Apr; 51(4):1029-36. PubMed ID: 8483258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
